Revolution Medicines Inc.

Last updated September 27, 2026

Organization details

Legal name
Revolution Medicines Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Redwood City
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
RVMD
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001628171
EIN
47-2029180
Wikidata ID
Q107518109

Board of directors

Director election results

Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 14 other boards. 14 are in the same sector.

Network of Revolution Medicines Inc.'s board connections Cencora Inc. Cencora Inc. Parabilis Medicines Inc. Parabilis Medicines In... Tango Therapeutics Inc. Tango Therapeutics Inc... BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... Gilead Sciences Inc. Gilead Sciences Inc. Insmed Incorporated Insmed Incorporated Kailera Therapeutics Inc. Kailera Therapeutics I... Moderna Inc. Moderna Inc. OPKO Health Inc. OPKO Health Inc. Olema Pharmaceuticals Inc. Olema Pharmaceuticals... Pliant Therapeutics Inc. Pliant Therapeutics In... Relay Therapeutics Inc. Relay Therapeutics Inc... Relmada Therapeutics Inc. Relmada Therapeutics I... Replimune Group Inc. Replimune Group Inc. Alexis Borisy Alexis Borisy Barbara Weber Barbara Weber Elizabeth M. Anderson Elizabeth M. Anderso... Eric Thomas Schmidt Eric Thomas Schmidt Flavia Borellini Flavia Borellini Frank Clyburn Frank Clyburn Lorence H. Kim Lorence H. Kim Sandra Horning Sandra Horning Sushil Patel Sushil Patel Revolution Medicines Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$151,762,848
157 sales by 12 insiders
Date Insider Transaction Shares Price Value
Oct 26, 2026 Mancini Anthony Officer (See Remarks) Option exercise +2,310 $33.62 $77,662
Oct 26, 2026 Mancini Anthony Officer (See Remarks) Open-market sale −2,310 $186.99 $431,947
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Option exercise +6,000 $58.84 $353,040
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Open-market sale −2,200 $200.82 $441,801
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Open-market sale −1,609 $201.72 $324,574
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Open-market sale −1,000 $202.81 $202,813
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Open-market sale −1,199 $203.91 $244,485
Sep 29, 2026 Alan B. Sandler Officer (Chief Development Officer) Open-market sale −301 $204.72 $61,621
Sep 25, 2026 Cislini Jeff Officer (SVP & General Counsel) Open-market sale −765 $207.32 $158,600
Sep 25, 2026 Mancini Anthony Officer (See Remarks) Option exercise +3,121 $33.62 $104,928
Sep 25, 2026 Mancini Anthony Officer (See Remarks) Open-market sale −3,121 $200.54 $625,885
Sep 24, 2026 Mancini Anthony Officer (See Remarks) Open-market sale −587 $200.00 $117,400
Sep 22, 2026 Elizabeth M. Anderson Director Option exercise +5,070 $1.12 $5,678
Sep 22, 2026 Elizabeth M. Anderson Director Open-market sale −910 $191.85 $174,584
Sep 22, 2026 Elizabeth M. Anderson Director Open-market sale −4,985 $192.54 $959,812

Organizations in the same sector, closest in location and size first.

Questions about Revolution Medicines Inc.

How many directors are on Revolution Medicines Inc.'s board?

Revolution Medicines Inc.'s board has 11 directors: Alexis Borisy, Barbara Weber, Elizabeth M. Anderson, Eric Thomas Schmidt, Flavia Borellini, Frank Clyburn, Lorence H. Kim, Mark A. Goldsmith, Sandra Horning, Sushil Patel and 1 other.

Are Revolution Medicines Inc. insiders buying or selling shares?

Over the last 12 months, Revolution Medicines Inc. insiders made no open-market purchases and sold $151.8 million of shares in 157 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="revolution-medicines-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.